AZIN1 and cancer: Although the disparate nature of our cohort prevented systematic discovery of cancer-specific or prognostic editing events (e.g. similar to AZIN1 in hepatocellular carcinoma [8]), over 500 genes had RDDs predicted to result in deleterious amino acid substitutions, a large proportion of which were recurrent.